Related Experiment Video
Updated: Jul 30, 2026
04:48
Rose Bengal-Mediated Photodynamic Therapy to Inhibit Candida albicans
Published on: March 24, 2022
Mucormycosis. Adjunctive therapy with hydrogen peroxide
1Department of Otolaryngology-Head & Neck Surgery, Virginia Commonwealth University/Medical College of Virginia, Richmond, USA.
Virginia Medical Quarterly : VMQ
|January 1, 1996
Summary
Topical hydrogen peroxide soaks offer a novel adjunctive treatment for mucormycosis, a severe fungal infection. This approach showed success in two diabetic patients unresponsive to standard therapies.
Area of Science:
- Mycology
- Infectious Diseases
- Otolaryngology
Background:
- Mucormycosis is a life-threatening fungal infection primarily affecting immunocompromised individuals, including diabetics.
- Standard treatments like surgical debridement and Amphotericin B have limitations and variable success rates.
- Alternative and adjunctive therapies are crucial for managing refractory cases.
Observation:
- Two diabetic patients with severe, recurrent mucormycosis (rhinoorbital and sphenoid sinus) showed no improvement with intravenous Amphotericin B.
- Both patients had undergone prior surgical interventions (maxillectomy and endoscopic sinus surgery).
Findings:
- Application of 1/2 strength topical hydrogen peroxide soaks led to the apparent eradication of fungal infections in both patients.
- Hydrogen peroxide likely exerts its antifungal effect through oxidation, potentially affecting both the fungus and surrounding tissues.
- This suggests a novel mechanism for treating mucormycosis.
Implications:
- Topical hydrogen peroxide soaks may represent a valuable, accessible adjunctive treatment for mucormycosis.
- Further research is warranted to validate the efficacy and safety of this therapeutic approach.
- This could offer a new strategy for managing devastating fungal infections in vulnerable patient populations.
More Related Videos
Related Concept Videos
01:23Skin Diseases and Disorders
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
01:29Fungal Group Zygomycota
Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...